Address And Details

922 Walnut St., 4th Floor , Kansas City, MO 64106
Fund Manager Scott M. Colbert
Manager Tenure 26 Years 10 Months

Strategy And Objective

The investment objective of the Fund is to seek current income with preservation of principal. Under normal market conditions, the Fund invests at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in securities issued or guaranteed by the U.S. Government, its agencies or instrumentalities (including U.S. Treasury bills, notes, bonds and inflation-protected obligations) and government mortgage-backed securities (pools of mortgage loans sold to investors by various governmental agencies). The Fund may also purchase other mortgage-backed and asset-backed securities, which are sold by private issuers. The Fund will provide shareholders with at least 60 days notice before changing its 80% investment policy.

Net Asset Value

as of 5:48 PM ET 10/18/2021


  • 1 Week
  • -0.24%
  • 1 Month
  • -0.65%
  • 3 Months
  • -1.00%
  • 1 Yr Return
  • -2.37%
  • 5 Yr Return
  • -2.82%

Equity Sector Breakdown

ConsumerDurables n/a
Energy n/a
Finance n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Bonds 98.27%
Cash 4.71%
Stocks 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Other -2.98%
Total Net Assets 66.58 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 0.20 -0.27 -0.12
Beta 0.26 0.27 0.29
R Squared 0.67 0.38 0.44
Std Deviation 1.09 1.44 1.28
Sharpe Ratio 1.21 0.17 n/a

Purchase Information

as of 6:02 PM ET 10/15/2021
Minimum Initial $1000
Minimum Additional $250
Minimum Initial IRA $1000


Timeframe Average Annual Current Performance Monthly As Of 09/30/2021 Average Annual Current Performance Quarterly As Of 09/30/2021 Avg Annual Current Performance Monthly As Of 09/30/2021 Avg Annual Current Performance Quarterly As Of 09/30/2021
1 Year
  • -0.34%
  • -0.34%
-0.34% -0.34%
3 Year
  • +2.36%
  • +2.36%
+2.36% +2.36%
10 Year
  • +1.23%
  • +1.23%
+1.23% +1.23%
Life Of Fund
  • +3.60%
  • +3.60%
+3.60% +3.60%

Top 10 Holdings

Symbol Company Name % Of Assets

Recent Articles from TheStreet

What to Watch Tuesday: Procter & Gamble Earnings, Inflation Data

Premarket Movers Tuesday - Procter & Gamble, Ulta, Netflix

Stocks moving in premarket trading include Procter & Gamble. Ulta, Netflix, Johnson & Johnson and Teladoc.

After Red-hot IPO, Chinese Biotech Firm Kintor Eyes Blockbuster Drugs For Prostate Cancer, Sex Hormone-related Hair Loss

Atea Pharma Stock Plunges After COVID Treatment Trial Disappoints; Merck Jumps

Atea Pharmaceuticals could shed more than $2 billion in value Tuesday after the drugmaker said a mid-stage trial of its developing COVID treatment failed to meet expectations.

What to know about Cloudflare's Upcoming IPO

Investing in the Cloud: Consider Cloudflare and Digital Ocean

Cloud-software growth stocks have been a bright spot in an uncertain market. Investors might look closely at Cloudflare and Digital Ocean.

Philip Morris International Lead

Philip Morris Ekes Out Third-Quarter Earnings Beat

Philip Morris posts a third-quarter earnings beat as sales of its smokeless non-tobacco products continue strong, though cautions on supply chain impact.

The Travelers Companies Lead

Travelers Posts Third Quarter Earnings Beat on Record Net Written Premiums

Travelers Companies posts third-quarter earnings that exceed analysts’ forecasts as a drop in what it calls ‘catastrophic losses’ offsets record net written premiums.

Lufax is set to make the biggest splash on the NYSE by a Chinese company since e-commerce giant Alibaba's IPO in 2014. Photo: Reuters

Stock Market Today: Dow Gains On Earnings Strength; Housing Starts Disappoint

Solid third quarters continue to power stocks higher Tuesday, even as growth and inflation signals remain stubbornly persistent as oil prices top $85 a barrel in overnight trading.

Procter & Gamble Is Under Siege From an Activist Investor

Procter & Gamble Stock Slips After Q1 Earnings Beat; 2022 Forecast Unchanged

Procter & Gamble held its 2022 forecasts in place, seeing sales growth of between 2% and 4%, following stronger-than-expected first quarter earnings.

No More Tears for Johnson & Johnson?

Johnson & Johnson Stock Gains as Vaccine Sales Boost Q3 Earnings, 2021 Forecasts

Johnson & Johnson said it sees 2021 vaccine sales of $2.5 billion, with overall revenues rising to between $94.1 billion to $94.6 billion, following its Q3 earnings beat.

Stock Market Lead

Stocks Gain, SEC GameStop Report, Rent The Runway IPO - 5 Things You Must Know

Stocks edge higher ahead of earnings; SEC says GameStop surge powered by believers; FDA set to approve "mix & match' COVID boosters; DraftKings faces Entain bid deadline and Rent the Runway seeks $1.3 billion valuation in Nasdaq IPO.